Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study Meeting Abstract
| Authors: | Tron, C.; Lemaitre, F.; Locher, C.; Lecomte, T.; Tournigand, C.; Bouhier Leporrier, K.; Le Sourd, S.; Metges, J. P.; Tougeron, D.; Di Fiore, F.; Hervé, C.; Heran, M.; Touchefeu, Y.; Rousseau, B. J. C.; Hulin, A.; Lievre, A. |
| Abstract Title: | Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S739 |
| End Page: | S740 |
| Language: | English |
| ACCESSION: | WOS:000866211600443 |
| DOI: | 10.1016/j.annonc.2022.07.1870 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 449TiP -- Source: Wos |
